02/13/2020
This article looks at the decade ahead for personalized healthcare and precision medicine. Four Industry leaders give their thoughts on where we have been and where we are going in the decade ahead. The consensus of their opinion is that individuals need to become more engaged in the generation and guardianship of their healthcare information. Artificial Intelligence methods will need to be developed so that this vast amount of data can be interpreted and used in the healthcare of the individual.
Central to this development is an understanding by the individual that their healthcare information is private, belongs to them and must only be used with their permission. This is not the case today where companies such as Google, Facebook and Apple collect information and use it to generate important data sets without the individual’s consent.
Important as well is the quality of the data sets that are generated. One big omission is the lack of longitudinal data sets, meaning that information is not continuous and reflective of the life of the individual. With the participation of individuals, these longitudinal data sets can be generated and used to guide individual health decisions to effect good health outcomes.
Cord blood storage provides a key starting point in the generation of these longitudinal data sets. The stem cells can be analyzed for a variety of health data that includes DNA, RNA and Proteomics. This pristine information will form the basis for all future comparisons in the health care journey of the individual as they interact with the environment, microbes, and chemicals to name a few influences. In summary, indivualized health care is at hand and will be harnessed in the coming decade in concert with AI algorithms. Precision medicine is just around the corner.
Four industry watchers share their thought on what may happen in the next ten years to advance the field of precision medicine and/or genomic medicine.